REGEMAT 3D Celebrates Record Year of Scientific Impact in 2024

Granada, Spain – January 10, 2025 – REGEMAT 3D proudly announces that 2024 marked
a record year in scientific publications citing its technologies, highlighting the growing
global relevance of its 3D bioprinters, bioinks, and bioreactors in regenerative medicine
and tissue engineering.
Throughout the year, researchers across the globe leveraged REGEMAT 3D’s solutions to
drive innovation in areas ranging from bone and cartilage regeneration to personalized
tissue models and antimicrobial device coatings.
Key highlights of 2024 include:

The global impact of REGEMAT 3D’s technologies across diverse biomedical
applications

Strong and expanding collaborations with leading academic and clinical institutions

Steady growth in adoption by researchers and innovators worldwide
We extend our deepest gratitude to the scientific community, whose trust and partnership
have enabled these achievements. REGEMAT 3D remains committed to supporting
groundbreaking research and advancing the future of biofabrication.

✨Here’s to continued progress and innovation in 2025. Happy New Year from the
REGEMAT 3D team!
For more information and to explore recent publications, visit www.regemat3d.com